The PETITE-DTG study evaluated the dosing and safety of dolutegravir (DTG) in neonates born to mothers living with HIV. The study assessed a pediatric dispersible tablet and an oral film, finding the dosing strategy to be safe and effective. The PETITE PLATFORM aims to accelerate neonatal dosing recommendations for ARVs, with the goal of expanding access to the latest advancements in HIV care for newborns. The study showed high levels of acceptability for both DTG formulations, potentially improving HIV prevention and treatment options for neonates.
Full Article
News24 | Forensic report recommends disciplinary action against IDT CEO over R800m oxygen plant tender
A forensic investigation into a R800 million oxygen plant tender awarded by the Independent Development Trust (IDT) has recommended disciplinary action against CEO Tebogo Malaka, general manager Molebedi Sisi, and other officials for misconduct. The findings highlight significant irregularities in the tender process, raising concerns about governance and accountability within the IDT. Want More Context? 🔎
Read more